5-carbamoyl-1h-imidazol-4-yl-piperonylate has been researched along with Lung Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atsumi, T; Fukui, M; Inaba, M; Kiyohara, T; Ogino, S; Sakurai, Y; Tsukagoshi, S; Yoshida, N | 1 |
1 other study(ies) available for 5-carbamoyl-1h-imidazol-4-yl-piperonylate and Lung Neoplasms
| Article | Year |
|---|---|
Antitumor activities of newly synthesized 5-carbamoyl-1 H-imidazol-4yl 1-adamantanecarboxylate and 5-carbamoyl-1H-imidazol-4yl piperonylate.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Colonic Neoplasms; Imidazoles; Injections, Intraperitoneal; Leukemia P388; Life Expectancy; Lung Neoplasms; Male; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Prognosis | 1980 |